Patent Oppositions in material analysis industry

Explore the competitive field of material analysis where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in material analysis technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the material analysis industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the material analysis industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 1, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Semi-Automated Patch-Clamp Apparatus And A Method For Carrying Out A Patch-Clamp ProcedureSOPHION BIOSCIENCESep 24, 2026NANION
Compositions And Methods For Analyte DetectionPRESIDENT AND FELLOWS OF HARVARD COLLEGEAug 7, 2026ELEMENT BIOSCIENCES NETHERLANDS B.V.
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 29, 2026STORZ
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 28, 2026PAJARO
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 27, 2026GREINER
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 17, 2026POHLMAN
Compositions And Methods For Analyte DetectionPRESIDENT AND FELLOWS OF HARVARD COLLEGEJul 15, 2026ELEMENT BIOSCIENCES NETHERLANDS B.V.
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 13, 2026MANZER
Improved Methods Of Assessing Gfap Status In Patient SamplesABBOTT LABORATORIESJun 26, 2026ARROWHOUSE
Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19FMERCK SHARP & DOHMEJun 24, 2026SANOFI VACCINES

To stay ahead in the competitive material analysis industry, companies are constantly innovating. Here are the top patents facing oppositions in the material analysis industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 1, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Aug 24, 2022Compositions And Uses For Treating Multiple SclerosisBIOGEN MA15
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
Oct 29, 2025Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBB9
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS7
Oct 19, 2016Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYO6
Mar 28, 2018Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHA6
Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECH6
Jan 10, 2024Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALS6
Nov 2, 2016Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)PathwayEMORY UNIVERSITY5